Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/2/16 → 12/31/20 |
Funding
- Astellas Pharma Global Development Incorporated: $202,826.30
Astagraf XL to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation
- Laftavi, Mark (PI)
Project: Research